The Ministry of Health confirmed on Tuesday that Algeria has not recorded any cases of human pneumovirus (HMPV), a respiratory virus primarily affecting young children and the elderly.
The Ministry of Health, Population, and Hospital Reform announced that the human pneumovirus (HMPV), first identified globally in 2001, has not been detected in Algeria. The statement clarified that the ministry’s National Influenza Surveillance Network is actively monitoring seasonal influenza viruses, particularly as colder weather increases the likelihood of virus transmission.
To minimize the spread and complications of seasonal influenza, the ministry emphasized that the influenza vaccination campaign for the 2024-2025 season remains underway. The vaccination program targets individuals over 65, those with chronic conditions, pregnant women, and children. Vaccines are available free of charge at public health institutions and can also be accessed at private pharmacies, with social security covering costs for insured individuals.
The ministry reiterated the importance of preventive measures to curb the spread of respiratory viruses, including:
Avoiding contact with sick individuals.
Regularly washing hands with soap and water or using an alcohol-based sanitizer.
Covering the mouth and nose when coughing or sneezing.
Using disposable tissues for nasal hygiene.
The statement also highlighted the prevalence of other winter respiratory viruses, such as the respiratory syncytial virus (RSV), which can lead to bronchiolitis or pneumonia, particularly in young children. Common symptoms of winter respiratory illnesses include fever, cough, runny nose, and wheezing.
The Ministry of Health urges continued vigilance, vaccination, and adherence to preventive measures to mitigate the spread of seasonal and respiratory viruses during the winter season.
Comentarios